2021
DOI: 10.1007/s00380-021-01835-w
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 26 publications
0
14
1
Order By: Relevance
“…While the previous study did not suggest a significant difference in the onset-to-door time [median (control period vs. COVID-19 period): 205 vs. 266 minutes, p=0.20] ( 9 ), our study revealed a significantly longer time during the COVID-19 period (128 vs. 241 minutes, p=0.028). Regarding the prognosis, while the 30-day cumulative mortality rates were comparable in the previous study (8.3% vs. 9.4%, p=0.772, log-rank test), they were found to be higher during the COVID-19 pandemic in the present study (6.6% vs. 13.7%, p=0.074, log-rank test).…”
Section: Discussioncontrasting
confidence: 99%
See 2 more Smart Citations
“…While the previous study did not suggest a significant difference in the onset-to-door time [median (control period vs. COVID-19 period): 205 vs. 266 minutes, p=0.20] ( 9 ), our study revealed a significantly longer time during the COVID-19 period (128 vs. 241 minutes, p=0.028). Regarding the prognosis, while the 30-day cumulative mortality rates were comparable in the previous study (8.3% vs. 9.4%, p=0.772, log-rank test), they were found to be higher during the COVID-19 pandemic in the present study (6.6% vs. 13.7%, p=0.074, log-rank test).…”
Section: Discussioncontrasting
confidence: 99%
“…In Japan, limited studies have reported the time course and STEMI outcomes during the early COVID-19 pandemic. A single-center retrospective cohort study from Tokyo showed no significant differences in the time course or 30-day mortality in STEMI patients before and after the COVID-19 outbreak ( 9 ), while another study from Osaka reported that the in-hospital mortality was comparable, despite an increased incidence of late presentation and mechanical complications of STEMI ( 10 ). In contrast, we demonstrated treatment delays and a tendency toward increased STEMI mortality during this pandemic; however, the increment in mortality was not significant.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, tertiary centres have reported a decline in the number of patients presenting with myocardial infarction during the pandemic, particularly those with no-ST segment elevation myocardial infarction [ 20 ], with studies demonstrating longer times from symptom onset to presentation [ 21 ] and of patients declining hospital admission [ 22 ]. Given that further pandemic-related lockdowns are a possibility going forward, it is imperative that we deliver the message to older people that deferring medical assessment and care when unwell is unsafe and generally not in their best interests, particularly in the case of complaints such as chest pain or acute neurological symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, 56 records were excluded based on several reasons: 1) outcomes of interest were not relevant ( n = 31); 2) a comparison between two period was not reported ( n = 16); 3) articles were case report/series ( n = 9). Eventually, a total of 35 studies with 62,247 participants 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 were evaluated in our meta-analysis. STEMI patients who presented in the pandemic period were older, predominately from male population, had a higher prevalence of comorbid conditions, and had worse cardiac function during hospital admission.…”
Section: Resultsmentioning
confidence: 99%